Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by newdaydawningon Oct 07, 2017 7:17pm
148 Views
Post# 26789914

RE:RE:RE:Options....

RE:RE:RE:Options....PP is almost certain. And you're right the market will likely over sell placement price, particularly among shareholders who sell because they are mad. That's the worst reason to sell. But those who see the big picture will take the opportunity to expand their position. My call is 10M shares @$0.40. If the price is lower, expect a more intense sell off.


skier59 wrote: No, I promise to be quiet if such happens. Already said, if a PP is announced you won't see me on this board for a very long time. If the market over reacts in a negative manner I will try and take advantage of any selling.

bionicjoe wrote:
skier59 wrote: for a financial instrument are many, without issuing another share. Dr Frost knows what we have and I bet big bucks, he wants to be involved and is hoping he can use our tech for his OPKO that is not generating any profits. Now why would he constantly buy up shares of OPKO if it never seems to generate profits ? Obviously he knows something we don't know, and why is it he appears to be in a Black-Out period preventing him to continue buying shares of OPKO at the same time that we all know TLT will require some sort of funding ? If he were to do a PP with Thalman Landberg it would not prevent him from continuing his purchses of OPKO. However anything else which might involve funds coming from OPKO certain would require him to stop his purchasing of OPKO shares. The plot thickens. Also even if a patient has to get a re-treatment 6-9-12 months down the road, who cares, certainly 100% better than anything else offered on the market, which BTW requires constant treatments. Hey more revenues.


Skier59, swear that you won't try and trash the sp in order to pick up cheap shares if RW announces another PP? I'm already expecting it from macman1519 but I hope you won't stoop to anything so low?




Bullboard Posts